| Bioactivity | Enpp-1-IN-16 (compound 54) is an ENPP1 inhibitor. Enpp-1-IN-16 has the potential to study cancer, especially in cases of high ENPP1 expression or elevated cytoplasmic DNA levels. Enpp-1-IN-16 can also be used in other diseases mediated by ENPP1, such as bacterial or viral infections, insulin resistance and type II diabetes, chondrocalcinosis and osteoarthritis, calcium pyrophosphate deposition disorder (CPPD), low Phosphatase disease and soft tissue calcification disorders[1]. | ||||||||||||
| Name | Enpp-1-IN-16 | ||||||||||||
| CAS | 2289739-47-3 | ||||||||||||
| Formula | C23H32N4O4 | ||||||||||||
| Molar Mass | 428.52 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Derek A Cogan, et al. Imino sulfanone inhibitors of enpp1. WO2021225969A1. |
Enpp-1-IN-16
CAS: 2289739-47-3 F: C23H32N4O4 W: 428.52
Enpp-1-IN-16 (compound 54) is an ENPP1 inhibitor. Enpp-1-IN-16 has the potential to study cancer, especially in cases of
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.